ResearcherGeorgetown UniversityActive in the last 2 years

Sivanesan Dakshanamurthy

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-3681-4121; OpenAlex author ID A5011155959. Sources: OpenAlex.

Their work

Papers: 2 (first author 1, last author 1)
Trials: 0
Grants: 0
Labs led: 1
Collaborators: 3

Papers, trials and grants by year

2022: 1 paper · 2023: none · 2024: 1 paper

Papers 2

Novel Methodology for the Design of Personalized Cancer Vaccine Targeting Neoantigens: Application to Pancreatic Ductal Adenocarcinoma. First author DOI 10.3390/diseases12070149 ↗
A novel chemo-phenotypic method identifies mixtures of salpn, vitamin D3, and pesticides involved in the development of colorectal and pancreatic cancer. Last author DOI 10.1016/j.ecoenv.2022.113330 ↗

Closest collaborators

The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Kush Savsani · 1 shared paper, 2024 · strength 0.46
- Paper Novel Methodology for the Design of Personalized Cancer Vaccine Targeting Neoantigens: Application to Pancreatic Ductal… DOI 10.3390/diseases12070149 ↗
Ivana Peran · 1 shared paper, 2022 · strength 0.14
- Paper A novel chemo-phenotypic method identifies mixtures of salpn, vitamin D3, and pesticides involved in the development of… DOI 10.1016/j.ecoenv.2022.113330 ↗
Naiem Tony Issa · 1 shared paper, 2022 · strength 0.14
- Paper A novel chemo-phenotypic method identifies mixtures of salpn, vitamin D3, and pesticides involved in the development of… DOI 10.1016/j.ecoenv.2022.113330 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.